Vanguard Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.8M | Buy |
|
|||||
|
2025
Q1 | $107M | Buy |
|
|||||
|
2024
Q4 | $89.7M | Sell |
|
|||||
|
2024
Q3 | $64.8M | Buy |
|
|||||
|
2024
Q2 | $57.1M | Buy |
|
|||||
|
2024
Q1 | $51.2M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Buy |
|
|||||
|
2023
Q3 | $15.3M | Buy |
|
|||||
|
2023
Q2 | $25.3M | Buy |
|
|||||
|
2023
Q1 | $28.4M | Buy |
|
|||||
|
2022
Q4 | $37.5M | Buy |
|
|||||
|
2022
Q3 | $43.1M | Buy |
|
|||||
|
2022
Q2 | $38.3M | Buy |
|
|||||
|
2022
Q1 | $29.5M | Buy |
|
|||||
|
2021
Q4 | $31.4M | Buy |
|
|||||
|
2021
Q3 | $35.6M | Sell |
|
|||||
|
2021
Q2 | $40.8M | Sell |
|
|||||
|
2021
Q1 | $44.3M | Buy |
|
|||||
|
2020
Q4 | $30.6M | Buy |
|
|||||
|
2020
Q3 | $25.1M | Buy |
|
|||||
|
2020
Q2 | $11.4M | Buy |
|
|||||
|
2020
Q1 | $5.23M | Buy |
|